跳至主要内容
临床试验/NCT06783192
NCT06783192已完成1 期

A Study to Assess the Effects of Single Oral Doses of MK-8527 on the Single-Dose Pharmacokinetics of an Oral Contraceptive (Levonorgestrel and Ethinyl Estradiol) in Healthy Adult Postmenopausal or Oophorectomized Female Subjects

Merck Sharp & Dohme LLC1 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2023年8月14日最近更新:
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
14
试验地点
1
主要终点
Area under the curve from dosing to infinity (AUC0-∞) of LNG alone and with MK-8527

研究概览

简要总结

This study is designed to assess the effect of a single dose of MK-8527 on the single-dose pharmacokinetics (PK) and the safety and tolerability of levonorgestrel/ethinyl estradiol (LNG/EE) in healthy adult postmenopausal or ovariectomized female participants.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • is in good overall health
  • assigned female at birth

排除标准

  • has a history of clinically significant endocrine, GI, cardiovascular, hematological, thromboembolic, hepatic, immunological, renal, respiratory, genitourinary, or major neurological (including stroke and chronic seizures) abnormalities or diseases
  • is mentally or legally incapacitated, has significant emotional problems at the time of prestudy (screening) visit or expected during the conduct of the study or has a history of clinically significant psychiatric disorder of the last 5 years
  • has a history of cancer (malignancy)

研究组 & 干预措施

Arm 1: All Participants

Experimental

Participants receive single doses of LNG/EE alone and in combination with a single dose of MK-8527.

干预措施: MK-8527 (Drug)

Arm 1: All Participants

Experimental

Participants receive single doses of LNG/EE alone and in combination with a single dose of MK-8527.

干预措施: LNG/EE (Drug)

结局指标

主要结局

Area under the curve from dosing to infinity (AUC0-∞) of LNG alone and with MK-8527

时间窗: Up to ~96 hours postdose

Maximum plasma concentration (Cmax) of LNG alone and with MK-8527

时间窗: Up to ~96 hours postdose

Time to Cmax (Tmax) of LNG alone and with MK-8527

时间窗: Up to ~96 hours postdose

Apparent half-life (t½) of LNG alone and with MK-8527

时间窗: Up to ~96 hours postdose

AUC0-∞ of EE alone and with MK-8527

时间窗: Up to ~72 hours postdose

Tmax of EE alone and with MK-8527

时间窗: Up to ~72 hours postdose

次要结局

  • Percentage of participants with ≥1 adverse event (AE)(Up to ~28 days)
  • Percentage of participants discontinuing from study therapy due to AE(Up to ~28 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验